Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial

NCT06813820 is registered in ClinicalTrials.gov with BioVentrix as lead sponsor.

NCT NCT06813820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06813820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
Lead sponsor
BioVentrix
Phase
Not applicable
Overall status
Recruiting
Start date
September 29, 2025
Completion date
August 31, 2032
Enrollment
135 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chf, left ventricle dilated, left ventricle remodeling